Ionis Pharmaceuticals, Inc.
IONS · NASDAQ
10/28/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $11,827 | $6,288 | $4,789 | $5,524 |
| - Cash | $338 | $297 | $264 | $242 |
| + Debt | $1,489 | $1,420 | $1,958 | $1,417 |
| Enterprise Value | $12,978 | $7,410 | $6,483 | $6,698 |
| Revenue | $157 | $452 | $132 | $227 |
| % Growth | -65.3% | 243.5% | -41.9% | – |
| Gross Profit | $154 | $448 | $130 | $223 |
| % Margin | 98.5% | 99.1% | 98.9% | 98.3% |
| EBITDA | -$94 | $150 | -$120 | -$81 |
| % Margin | -60.2% | 33.2% | -91.2% | -35.5% |
| Net Income | -$129 | $124 | -$147 | -$104 |
| % Margin | -82.1% | 27.3% | -111.6% | -46.1% |
| EPS Diluted | -0.8 | 0.68 | -0.93 | -0.66 |
| % Growth | -217.6% | 173.1% | -40.9% | – |
| Operating Cash Flow | -$131 | $151 | -$151 | -$116 |
| Capital Expenditures | -$3 | -$14 | -$13 | -$25 |
| Free Cash Flow | -$135 | $137 | -$163 | -$142 |